---
title: "Medtronic plc (MDT.US) — 公司概况"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/MDT.US/overview.md"
symbol: "MDT.US"
name: "Medtronic plc"
parent: "https://longbridge.com/zh-CN/quote/MDT.US.md"
datetime: "2026-04-05T12:50:56.445Z"
locales:
  - [en](https://longbridge.com/en/quote/MDT.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDT.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDT.US/overview.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/MDT.US/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MDT.US/overview.md)


# Medtronic plc (MDT.US) — 公司概况

## 基本信息

| 项目 | 详情 |
|------|--------|
| 行业 | Health Care Equipment |
| 交易所 | US Market |
| 地址 | Building Two, Parkmore Business Park West, Galway, Co. Galway, Ireland |
| 官网 | [www.medtronic.com](https://www.medtronic.com) |

## 公司简介

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.

## 核心管理层

| 名称 | 职位 |
|------|-------|
| Geoffrey Straub Martha | Chairman of the Board & CEO |
| Thierry Pieton | Executive VP & CFO |
| Brett A. Wall | Executive VP & President of Neuroscience Portfolio |
| Mark Ploof | Senior Vice President of Global Operations and Business Services |
| Denise L. Blomquist | VP, Global Controller & Chief Accounting Officer |
| Elizabeth G. Nabel | Independent Director |
| Craig Arnold | Lead Independent Director |
| Gregory Peter Lewis | Independent Director |
| Kendall J. Powell | Independent Director |

## 主要股东

| 名称 | 占比 | 报告日期 |
|------|-------|-------------|
| The Vanguard Group, Inc. | 10.04% | 2025-12-31 |
| BlackRock, Inc. | 9.39% | 2025-12-31 |
| State Street Global Advisors, Inc. | 4.80% | 2025-12-31 |
| JP Morgan Asset Management | 3.69% | 2025-12-31 |
| Capital Research and Management Company | 3.24% | 2025-12-31 |
| Geode Capital Management, LLC | 2.17% | 2025-12-31 |
| Massachusetts Financial Services Company | 1.63% | 2025-12-31 |
| BNY Mellon Asset Management | 1.40% | 2025-12-31 |
| Deutsche Asset & Wealth Management | 1.37% | 2025-12-31 |
| Norges Bank Investment Management | 1.34% | 2025-12-31 |

## 业务构成

| 业务线 | 营收 | 占比 |
|---------|---------|-------|
| Cardiovascular | 12481000000 | 37.12% |
| Neuroscience | 9846000000 | 29.28% |
| Medical Surgical | 8407000000 | 25% |
| Diabetes | 2755000000 | 8.19% |
| Other | 137000000 | 0.41% |
| Unallocated Other Adjustments | -90000000 | % |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Medtronic plc Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "Cardiovascular",
        "ratio": 37.12
      },
      {
        "segment": "Neuroscience",
        "ratio": 29.28
      },
      {
        "segment": "Medical Surgical",
        "ratio": 25
      },
      {
        "segment": "Diabetes",
        "ratio": 8.19
      },
      {
        "segment": "Other",
        "ratio": 0.41
      },
      {
        "segment": "Unallocated Other Adjustments",
        "ratio": null
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## 地区分布

| 地区 | 营收 | 占比 |
|--------|---------|-------|
| United States | 17171000000 | 51.2% |
| Rest of World | 16250000000 | 48.45% |
| Ireland | 116000000 | 0.35% |


---

> **免责声明: 本文仅供参考，不构成任何投资建议。**